Literature DB >> 10524367

Medical care expenditures for selected circulatory diseases: opportunities for reducing national health expenditures.

T A Hodgson1, A J Cohen.   

Abstract

OBJECTIVES: Circulatory system diseases are a significant burden in terms of morbidity, mortality, and use of health care services. This article presents total, per capita, and per condition US medical care expenditures in 1995 for circulatory diseases according to sex, age, and type of health service.
METHODS: Total personal health care expenditures estimated by the Health Care Financing Administration for each type of health care service are separated into components to estimate patient expenditures by age, sex, primary medical diagnosis, and health care service for all diseases of the circulatory system, heart disease, coronary heart disease, congestive heart failure, hypertensive disease, and cerebrovascular disease.
RESULTS: Expenditures for circulatory diseases totaled $127.8 billion in 1995 (17% of all personal health care expenditures), $486 per capita, and $1,636 per condition. Approximately one half of expenditures was for hospital care and 20% was for nursing home care. Heart disease accounted for 60% of circulatory expenditures. Expenditures increased with age and reached 35% of expenditures among persons aged 85 years and older, which was almost $7,000 per capita. These relationships vary somewhat according to the specific circulatory disease, type of health care, and age.
CONCLUSIONS: Expenditures increase with age and circulatory diseases can be expected to command an increasing share of national health expenditures as the number and proportion of the population that is elderly grows. The alteration of lifestyles and medical interventions provide many opportunities to prevent circulatory diseases and to reduce national health expenditures.

Entities:  

Mesh:

Year:  1999        PMID: 10524367     DOI: 10.1097/00005650-199910000-00004

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  17 in total

1.  Navigating the gray zones of stroke management for a graying population.

Authors:  Meng Lee; Bruce Ovbiagele
Journal:  Cerebrovasc Dis       Date:  2010-03-30       Impact factor: 2.762

2.  Return to Work After Acute Myocardial Infarction: Comparison Between Young Women and Men.

Authors:  Rachel P Dreyer; Xiao Xu; Weiwei Zhang; Xue Du; Kelly M Strait; Maggie Bierlein; Emily M Bucholz; Mary Geda; James Fox; Gail D'Onofrio; Judith H Lichtman; Héctor Bueno; John A Spertus; Harlan M Krumholz
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2016-02

3.  Multi-modal intervention to reduce cardiovascular risk among hypertensive older adults: Design of a randomized clinical trial.

Authors:  Thomas W Buford; Stephen D Anton; Anthony A Bavry; Christy S Carter; Michael J Daniels; Marco Pahor
Journal:  Contemp Clin Trials       Date:  2015-06-23       Impact factor: 2.226

Review 4.  Returning coronary heart disease patients to work: a modified perspective.

Authors:  Anil Mital; Anubhav Mital
Journal:  J Occup Rehabil       Date:  2002-03

5.  Forecasting the future economic burden of current adolescent overweight: an estimate of the coronary heart disease policy model.

Authors:  James Lightwood; Kirsten Bibbins-Domingo; Pamela Coxson; Y Claire Wang; Lawrence Williams; Lee Goldman
Journal:  Am J Public Health       Date:  2009-10-15       Impact factor: 9.308

Review 6.  The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs.

Authors:  Ali Yazdanyar; Anne B Newman
Journal:  Clin Geriatr Med       Date:  2009-11       Impact factor: 3.076

7.  Cost of stress urinary incontinence: a claims data analysis.

Authors:  Howard G Birnbaum; Stephanie A Leong; Emily F Oster; Kraig Kinchen; Peter Sun
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

8.  Coronary heart disease attributable to passive smoking: CHD Policy Model.

Authors:  James M Lightwood; Pamela G Coxson; Kirsten Bibbins-Domingo; Lawrence W Williams; Lee Goldman
Journal:  Am J Prev Med       Date:  2009-01       Impact factor: 5.043

Review 9.  Pharmacoeconomic burden of undertreating hypertension.

Authors:  Luca Degli Esposti; Giorgia Valpiani
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 10.  Hypertension and aging.

Authors:  Thomas W Buford
Journal:  Ageing Res Rev       Date:  2016-02-01       Impact factor: 10.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.